Results 171 to 180 of about 8,508 (214)
Vogt-Koyanagi-Harada-like uveitis with severe hyalitis during treatment by anti-programmed death 1 antibody for lung cancer: a case report. [PDF]
Liu X, Lu Y, Lu P, Zhang Y, Xia W.
europepmc +1 more source
Severe panuveitis - Uncommon presentation of cat scratch disease.
Hazidi SCM, Rosli AH, Jabbari AJ.
europepmc +1 more source
openaire
This nationwide population-based cohort study aimed to describe the use of intravitreal injections (IVTs) of anti-vascular endothelial growth factor (anti-VEGF) agents and corticosteroids in pregnant women in France and to report on the incidence of obstetric and neonatal complications.
Inés Ben Ghezala +2 more
exaly +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intravitreal Corticosteroid Therapy
JAMA Ophthalmology, 2012Dennis P Han, Dale K Heuer
exaly +3 more sources
The intravitreal use of corticosteroids
Expert Review of Ophthalmology, 2010The use of intravitreal steroids was first explored some 35 years ago, and the enthusiasm for its use has waxed and waned over that time. This article reviews the pharmacology of different corticosteroid agents and drug delivery systems. The literature on the utility of steroids is reviewed and categorized by retinal vascular disease entity, that is ...
Alejandro Oliver, Peter J Kertes
openaire +1 more source
Perspectives on Verteporfin Therapy Combined With Intravitreal Corticosteroids
Archives of Ophthalmology, 2006S INCE ITS APPROVAL IN 1999, photodynamic therapy (PDT) using verteporfin has become the most important strategy in the treatment of neovascular age-related macular degeneration (AMD). Verteporfin therapy has a proven benefit seen in many subtypes of choroidal neovascularization (CNV).
Ursula, Schmidt-Erfurth +2 more
openaire +2 more sources
The use of intravitreal corticosteroids, evidence-based and otherwise
Current Opinion in Ophthalmology, 2006To provide a current update on the use of intravitreal corticosteroids as a treatment for a variety of retinal diseases.Pharmacokinetic studies demonstrate that a single 4 mg injection of intravitreal triamcinolone acetonide is present in the vitreous for up to 3 months.
Stephen M, Conti, Peter J, Kertes
openaire +2 more sources
INTRAVITREAL CORTICOSTEROIDS IN THE TREATMENT OF EXOGENOUS FUNGAL ENDOPHTHALMITIS
Retina, 1992A rabbit model of exogenous Candida albicans endophthalmitis was used to determine if intravitreal corticosteroids combined with an efficacious antifungal agent enhanced fungal proliferation and ocular destruction, or if the combination can suppress the inflammatory and immunogenic response that causes retinal and uveal destruction.
M L, Coats, G A, Peyman
openaire +2 more sources

